Hypera S.A. HYPMY
3.76 USD -0.16 (-4.08%)
Nov 3, 2026, 2:20 PM EST
3.71 Day range 3.81
3.39 52-week range 5.77
- YTD
- -9.18%
- 1 year
- -16.44%
- Market cap
- 2.65B
- EPS (ttm)
- 0.52
- P/E ratio
- 7.23
- YTD return
- -9.18%
- 1-year return
- -16.44%
- Volume
- 7.35K
- Avg volume
- 101.80K
- Open
- 3.80
- Previous close
- 3.92
- Day's range
- 3.71 – 3.81
- 52-week range
- 3.39 – 5.77
- Earnings date
- Nov 11, 2026
3M -0.39 (-9.40%)
Next earnings
Nov 11, 2026
Expected Nov 11, 2026. Consensus EPS estimate 0.15.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2026 | Sep 30, 2026 | 0.15 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.13 | 0.14 | +0.01 | +7.69% |
| Apr 29, 2026 | Mar 31, 2026 | — | 0.10 | — | — |
| Mar 12, 2026 | Dec 31, 2025 | — | 0.13 | — | — |
| Nov 12, 2025 | Sep 30, 2025 | — | 0.13 | — | — |
| Aug 6, 2025 | Jun 30, 2025 | — | 0.12 | — | — |
News
Hypera S.A. (HYPMY) Q3 2026 Earnings Call Transcript 
Lyra Therapeutics (OTCMKTS:LYRA) versus Hypermarcas (OTCMKTS:HYPMY) Head-To-Head Analysis 
Hypermarcas (OTCMKTS:HYPMY) Reaches New 12-Month High – Should You Buy? 
Hypermarcas (OTCMKTS:HYPMY) Stock Price Up 8% – Should You Buy? 
Contrasting Hypermarcas (OTCMKTS:HYPMY) and Ensysce Biosciences (NASDAQ:ENSC) 
Hypermarcas (OTCMKTS:HYPMY) Shares Pass Below Two Hundred Day Moving Average – Here’s What Happened 
Hypera S.A. (HYPMY) Q2 2026 Earnings Call Transcript 
Hypermarcas (OTCMKTS:HYPMY) Sees Large Increase in Short Interest 
Hypermarcas (OTCMKTS:HYPMY) Short Interest Update - Hypermarcas (OTCMKTS:HYPMY) Short Interest Update
Your note
Sign in to keep a note on HYPMY — it syncs with the Stock Master app.